Your browser doesn't support javascript.
loading
Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report
Clinical Psychopharmacology and Neuroscience ; : 79-81, 2017.
Article in English | WPRIM | ID: wpr-41571
ABSTRACT
Dopamine supersensitivity psychosis (DSP) is a type of acute exacerbation of recurrent psychosis caused by long-term treatment with antipsychotics in schizophrenic patients. Although DSP is exceedingly troublesome for clinicians, effective treatment has not yet been established. Based on clinical research and our animal study, we hypothesize that aripiprazole, an atypical anti-psychotic, may reduce the exacerbation of recurrent psychotic episodes. We report the case of a 46-year-old female who suffered from schizophrenia with DSP. In this case, sustained treatment with a high dose of aripiprazole gradually reduced the severity of her recurrent psychotic episodes. In conclusion, sustained treatment with aripiprazole may reduce the exacerbation of recurrent psychotic episodes in schizophrenic patients with DSP, and may be an effective treatment of DSP.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Psychotic Disorders / Recurrence / Schizophrenia / Antipsychotic Agents / Dopamine / Receptors, Dopamine D2 / Disease Progression / Aripiprazole Limits: Animals / Female / Humans Language: English Journal: Clinical Psychopharmacology and Neuroscience Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Psychotic Disorders / Recurrence / Schizophrenia / Antipsychotic Agents / Dopamine / Receptors, Dopamine D2 / Disease Progression / Aripiprazole Limits: Animals / Female / Humans Language: English Journal: Clinical Psychopharmacology and Neuroscience Year: 2017 Type: Article